BCCT plans to write a summary on pomegranate. While our summary is in development, you can visit these sites:

Before using this therapy, consult your oncology team about interactions with other treatments and therapies. Also make sure this therapy is safe for use with any other medical conditions you may have.


Both the About Herbs and CAM-Cancer summaries of pomegranate list warnings, contraindications, adverse effects and herb-drug interactions. Read the summaries above for more information on cautions.

People who are allergic to pomegranate should avoid it, as there is the risk of anaphylactic shock. The high sugar content in pomegranate juice may aggravate diabetes.

If you are on medications and/or have a chronic health condition, consult your doctor or pharmacist to check for medications with which pomegranate will interact. For instance, pomegranate may interfere with some drug metabolism enzymes and increase the risk for muscle damage from statins.


BCCT does not recommend therapies or doses, but only provides information for patients and providers to consider as part of a complete treatment plan. Patients should discuss therapies with their physicians, as contraindications, interactions and side effects must be evaluated.

Dosage recommendations are available from these sources:

Integrative Programs, Protocols and Medical Systems

For more information about programs and protocols, see our Integrative Programs and Protocols page.
  • Programs and protocols
    • Alschuler & Gazella complementary approaches1
    • Block program2
      • Dietary component for molecular targeting (same targets as Avastin and Erbitux)
      • High-intensity nutritional support for cachexia (wasting)
      • Remission support diet
      • Dietary component to reduce platelet aggregation
    • Lemole, Mehta & McKee protocols: part of a whole-foods diet3
  • Traditional systems

View All References

More Information

Enter your comments or questions below.

Comments (0)

Allowed tags: <b><i><br>Add a new comment: